SARcode Corporation announced today that clinical data for their lead compound, SAR 1118, has been accepted for presentation during the upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting being held May 1-May 5, 2011, in…
SARcode Corporation To Present Phase 2 Clinical Data For Dry Eye Candidate At The ARVO2011 Annual Meeting
SARcode Corporation announced today that clinical data for their lead compound, SAR 1118, has been accepted for presentation during the upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting being held May 1-May 5, 2011, in…
Scotia Vision And I2eye Consulting Combine Businesses
Scotia Vision LLC, a global life science consulting partner to pharmaceutical, drug delivery and device companies, announced Monday that it has entered into a definitive merger agreement with i2eye Consulting LLC, a US based firm and provider of commer…
A Prospective, Randomized, Placebo and Active Comparator Controlled Study of CP-690,550 in Subjects With Dry Eye.
Status: Completed,
Condition Summary: Dry Eye Syndromes
Progress Seen In Creating Eye Cells From Stem Cells
To push the theoretical promise of stem cell research into the world of viable treatments, scientists have successfully fashioned adult stem cells into the kind of eye cells that fall victim to the onset of age-related macular degeneration, or AMD.
DSAEK Grafts Yield Greater Thickness, Haze Than PK
Patients who underwent Descemet’s stripping automated endothelial keratoplasty had increased corneal thickness and significantly more haze during follow-up than those who underwent penetrating keratoplasty, a study showed.